epilepsy society

5

epilepsy society Company Information

Share EPILEPSY SOCIETY
Live 
MatureMidLow

Company Number

00492761

Registered Address

epilepsy society chesham lane, chalfont st peter, buckinghamshire, SL9 0RJ

Industry

Other human health activities

 

Residential nursing care activities

 

Telephone

01494601400

Next Accounts Due

December 2024

Group Structure

View All

Directors

Deborah Wheeler11 Years

James Hagan8 Years

View All

Shareholders

-0%

epilepsy society Estimated Valuation

£17.1m

Pomanda estimates the enterprise value of EPILEPSY SOCIETY at £17.1m based on a Turnover of £17.9m and 0.96x industry multiple (adjusted for size and gross margin).

epilepsy society Estimated Valuation

£0

Pomanda estimates the enterprise value of EPILEPSY SOCIETY at £0 based on an EBITDA of £-1.4m and a 6.02x industry multiple (adjusted for size and gross margin).

epilepsy society Estimated Valuation

£69.9m

Pomanda estimates the enterprise value of EPILEPSY SOCIETY at £69.9m based on Net Assets of £28.1m and 2.48x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Epilepsy Society Overview

Epilepsy Society is a live company located in buckinghamshire, SL9 0RJ with a Companies House number of 00492761. It operates in the other human health activities sector, SIC Code 86900. Founded in March 1951, it's largest shareholder is unknown. Epilepsy Society is a mature, mid sized company, Pomanda has estimated its turnover at £17.9m with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Epilepsy Society Health Check

Pomanda's financial health check has awarded Epilepsy Society a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

7 Strong

positive_score

2 Regular

positive_score

2 Weak

size

Size

annual sales of £17.9m, make it larger than the average company (£2.5m)

£17.9m - Epilepsy Society

£2.5m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (5.2%)

1% - Epilepsy Society

5.2% - Industry AVG

production

Production

with a gross margin of 35.6%, this company has a comparable cost of product (35.6%)

35.6% - Epilepsy Society

35.6% - Industry AVG

profitability

Profitability

an operating margin of -11.5% make it less profitable than the average company (9.6%)

-11.5% - Epilepsy Society

9.6% - Industry AVG

employees

Employees

with 325 employees, this is above the industry average (66)

325 - Epilepsy Society

66 - Industry AVG

paystructure

Pay Structure

on an average salary of £27.9k, the company has an equivalent pay structure (£23.2k)

£27.9k - Epilepsy Society

£23.2k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £55.1k, this is more efficient (£41.3k)

£55.1k - Epilepsy Society

£41.3k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Epilepsy Society

- - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 21 days, this is slower than average (18 days)

21 days - Epilepsy Society

18 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 0 days, this is less than average (5 days)

0 days - Epilepsy Society

5 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 119 weeks, this is more cash available to meet short term requirements (76 weeks)

119 weeks - Epilepsy Society

76 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 21.5%, this is a lower level of debt than the average (39.6%)

21.5% - Epilepsy Society

39.6% - Industry AVG

EPILEPSY SOCIETY financials

EXPORTms excel logo

Epilepsy Society's latest turnover from March 2023 is £17.9 million and the company has net assets of £28.1 million. According to their latest financial statements, Epilepsy Society has 325 employees and maintains cash reserves of £9.1 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover17,899,00016,675,00015,956,00017,154,00028,014,00017,174,00017,056,00016,992,00016,389,00019,884,00016,837,00017,081,00018,874,00017,904,000
Other Income Or Grants00000000000000
Cost Of Sales11,535,30610,830,31410,577,84811,168,71218,362,52511,010,86610,763,03010,721,71510,282,93112,382,71010,257,72710,146,07411,075,80610,496,070
Gross Profit6,363,6945,844,6865,378,1525,985,2889,651,4756,163,1346,292,9706,270,2856,106,0697,501,2906,579,2736,934,9267,798,1947,407,930
Admin Expenses8,414,9346,179,8684,092,2098,071,410-2,709,4296,035,2806,029,7367,321,7206,225,9643,813,9444,465,1855,242,7085,416,5047,171,416
Operating Profit-2,051,240-335,1821,285,943-2,086,12212,360,904127,854263,234-1,051,435-119,8953,687,3462,114,0881,692,2182,381,690236,514
Interest Payable000000014,23516,965249,8930000
Interest Receivable00000000000000
Pre-Tax Profit-1,512,000-213,0001,055,000-2,070,00010,096,000129,000215,000-1,035,000-108,0002,665,0001,252,000903,0001,377,0003,000
Tax00000000000000
Profit After Tax-1,512,000-213,0001,055,000-2,070,00010,096,000129,000215,000-1,035,000-108,0002,665,0001,252,000903,0001,377,0003,000
Dividends Paid00000000000000
Retained Profit-1,512,000-213,0001,055,000-2,070,00010,096,000129,000215,000-1,035,000-108,0002,665,0001,252,000903,0001,377,0003,000
Employee Costs9,060,0009,073,0009,493,0009,576,0009,159,0009,803,00010,458,00010,582,00010,565,00010,645,00010,191,00010,720,00012,132,00012,107,000
Number Of Employees325373276280307334391396382347336326345364
EBITDA*-1,404,240309,8182,019,943-1,375,12213,103,9041,169,8541,306,23462,565699,1054,606,3462,967,0882,554,2183,331,6901,016,514

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets14,661,00014,969,00015,474,00016,114,00016,575,00046,102,00046,997,00047,939,00048,916,00024,603,00031,016,00030,275,00030,005,00027,374,000
Intangible Assets80,00092,000125,00001,00012,00037,00077,000112,00000000
Investments & Other9,478,0004,440,0004,440,0002,200,0002,200,0002,610,0002,610,0002,610,0002,610,000010,00010,00010,000118,000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets24,219,00019,501,00020,039,00018,314,00018,776,00048,724,00049,644,00050,626,00051,638,00024,603,00031,026,00030,285,00030,015,00027,492,000
Stock & work in progress23,00016,00015,00060,00063,00053,00047,00037,00037,00041,00051,00039,00040,00064,000
Trade Debtors00185,000469,00099,000593,000525,000694,000616,00000816,000836,000721,000
Group Debtors00000000000000
Misc Debtors1,621,0001,837,0001,234,000887,000545,000575,0001,262,000556,000982,000636,000833,000300,000372,000430,000
Cash9,124,00016,252,00016,330,00018,675,00020,340,0009,032,0007,352,0006,786,0005,482,0006,062,0003,372,0002,535,0002,386,0004,197,000
misc current assets869,0000000000000000
total current assets11,637,00018,105,00017,764,00020,091,00021,047,00010,253,0009,186,0008,073,0007,117,0006,739,0004,256,0003,690,0003,634,0005,412,000
total assets35,856,00037,606,00037,803,00038,405,00039,823,00058,977,00058,830,00058,699,00058,755,00031,342,00035,282,00033,975,00033,649,00032,904,000
Bank overdraft00000000000000
Bank loan00032,00048,00048,00048,00041,000000000
Trade Creditors 689,000531,000314,000989,000516,0001,128,0001,068,0001,140,000782,000974,000989,000000
Group/Directors Accounts000333,000244,000000000000
other short term finances00000000000000
hp & lease commitments00086,000111,00097,00080,000118,00092,00089,0000000
other current liabilities3,288,0002,583,0002,708,0002,178,0002,043,0001,942,0001,966,0001,954,0001,494,0001,048,0001,031,0001,803,0002,127,0002,363,000
total current liabilities3,977,0003,114,0003,022,0003,618,0002,962,0003,215,0003,162,0003,253,0002,368,0002,111,0002,020,0001,803,0002,127,0002,363,000
loans000031,00076,000122,000178,000219,000303,0007,386,0007,429,0007,471,0007,472,000
hp & lease commitments000087,000206,000323,000382,000500,000592,0000000
Accruals and Deferred Income00000000000000
other liabilities00000000000000
provisions00000000000000
total long term liabilities3,730,0006,550,0009,555,0008,708,0009,682,00010,794,00010,644,0007,829,0007,807,0005,815,00013,748,00012,452,00010,087,00013,236,000
total liabilities7,707,0009,664,00012,577,00012,326,00012,644,00014,009,00013,806,00011,082,00010,175,0007,926,00015,768,00014,255,00012,214,00015,599,000
net assets28,149,00027,942,00025,226,00026,079,00027,179,00044,968,00045,024,00047,617,00048,580,00023,416,00019,514,00019,720,00021,435,00017,305,000
total shareholders funds28,149,00027,942,00025,226,00026,079,00027,179,00044,968,00045,024,00047,617,00048,580,00023,416,00019,514,00019,720,00021,435,00017,305,000
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit-2,051,240-335,1821,285,943-2,086,12212,360,904127,854263,234-1,051,435-119,8953,687,3462,114,0881,692,2182,381,690236,514
Depreciation609,000612,000711,000710,000732,0001,015,0001,003,0001,077,000782,000919,000853,000862,000950,000780,000
Amortisation38,00033,00023,0001,00011,00027,00040,00037,00037,00000000
Tax00000000000000
Stock7,0001,000-45,000-3,00010,0006,00010,0000-4,000-10,00012,000-1,000-24,00064,000
Debtors-216,000418,00063,000712,000-524,000-619,000537,000-348,000962,000-197,000-283,000-92,00057,0001,151,000
Creditors158,000217,000-675,000473,000-612,00060,000-72,000358,000-192,000-15,000989,000000
Accruals and Deferred Income705,000-125,000530,000135,000101,000-24,00012,000460,000446,00017,000-772,000-324,000-236,0002,363,000
Deferred Taxes & Provisions00000000000000
Cash flow from operations-332,240-17,1821,856,943-1,476,12213,106,9041,818,854699,2341,228,565-4,8954,815,3463,455,0882,323,2183,062,6902,164,514
Investing Activities
capital expenditure000011,361,000-119,000-67,000-101,000-214,0009,265,000-1,485,000-1,132,000-1,976,000-3,146,000
Change in Investments5,038,00002,240,0000-410,0000002,610,000-10,00000-108,000118,000
cash flow from investments-5,038,0000-2,240,000011,771,000-119,000-67,000-101,000-2,824,0009,275,000-1,485,000-1,132,000-1,868,000-3,264,000
Financing Activities
Bank loans00-32,000-16,000007,00041,000000000
Group/Directors Accounts00-333,00089,000244,000000000000
Other Short Term Loans 00000000000000
Long term loans000-31,000-45,000-46,000-56,000-41,000-84,000-7,083,000-43,000-42,000-1,0007,472,000
Hire Purchase and Lease Commitments00-86,000-112,000-105,000-100,000-97,000-92,000-89,000681,0000000
other long term liabilities00000000000000
share issue1,719,0002,929,000-1,908,000970,000-27,885,000-185,000-2,808,00072,00025,272,0001,237,000-1,458,000-2,618,0002,753,00017,302,000
interest0000000-14,235-16,965-249,8930000
cash flow from financing1,719,0002,929,000-2,359,000900,000-27,791,000-331,000-2,954,000-34,23525,082,035-5,414,893-1,501,000-2,660,0002,752,00024,774,000
cash and cash equivalents
cash-7,128,000-78,000-2,345,000-1,665,00011,308,0001,680,000566,0001,304,000-580,0002,690,000837,000149,000-1,811,0004,197,000
overdraft00000000000000
change in cash-7,128,000-78,000-2,345,000-1,665,00011,308,0001,680,000566,0001,304,000-580,0002,690,000837,000149,000-1,811,0004,197,000

epilepsy society Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for epilepsy society. Get real-time insights into epilepsy society's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Epilepsy Society Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for epilepsy society by selecting its closest rivals and benchmarking them against 12 key performance metrics.

epilepsy society Ownership

EPILEPSY SOCIETY group structure

Epilepsy Society has 2 subsidiary companies.

Ultimate parent company

EPILEPSY SOCIETY

00492761

2 subsidiaries

EPILEPSY SOCIETY Shareholders

--

epilepsy society directors

Epilepsy Society currently has 12 directors. The longest serving directors include Ms Deborah Wheeler (Sep 2012) and Mr James Hagan (Nov 2015).

officercountryagestartendrole
Ms Deborah WheelerUnited Kingdom61 years Sep 2012- Director
Mr James HaganUnited Kingdom72 years Nov 2015- Director
Mrs Catherine AlcockEngland67 years Dec 2015- Director
Mr Andrew Gosling69 years Dec 2021- Director
Mr Andrew GrayUnited Kingdom61 years Dec 2021- Director
Ms Tracie Coultas-PitmanUnited Kingdom52 years Mar 2022- Director
Ms Jacqueline SullivanUnited Kingdom65 years Mar 2022- Director
Mrs Hannah PurvesUnited Kingdom51 years Dec 2023- Director
Dr Karen SkinnerUnited Kingdom54 years Dec 2023- Director
Mrs Rae Avatar BarnettUnited Kingdom60 years Dec 2023- Director

P&L

March 2023

turnover

17.9m

+7%

operating profit

-2.1m

0%

gross margin

35.6%

+1.43%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

28.1m

+0.01%

total assets

35.9m

-0.05%

cash

9.1m

-0.44%

net assets

Total assets minus all liabilities

epilepsy society company details

company number

00492761

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86900 - Other human health activities

87100 - Residential nursing care activities

incorporation date

March 1951

age

73

accounts

Group

ultimate parent company

None

previous names

national society for epilepsy(the) (March 2018)

national society for epileps (the) (December 1979)

incorporated

UK

address

epilepsy society chesham lane, chalfont st peter, buckinghamshire, SL9 0RJ

last accounts submitted

March 2023

epilepsy society Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 8 charges/mortgages relating to epilepsy society. Currently there are 0 open charges and 8 have been satisfied in the past.

charges

epilepsy society Companies House Filings - See Documents

datedescriptionview/download